Atossa Therapeutics Inc (NAS:ATOS)
$ 1.33 0.01 (0.76%) Market Cap: 167.26 Mil Enterprise Value: 82.67 Mil PE Ratio: 0 PB Ratio: 1.96 GF Score: 40/100

Atossa Therapeutics Inc at Sidoti & Company March Small-Cap Virtual Conference Transcript

Mar 23, 2023 / 05:00PM GMT
Release Date Price: $0.6793 (-5.14%)
Mitra Ramgopal
Sidoti & Co. LLC - Moderator

Okay. Good afternoon, everyone, and welcome to the Sidoti March Virtual Small-Cap Investor Conference. My name is Mitra Ramgopal. I'll be hosting our next presenter, Atossa Therapeutics. Representing the company today is CFO, Kyle Guse.

As a reminder, all in, it's 30 minutes. There will be some time for Q&A. So please type any questions you may have in the Q&A tab. I'll try to relay as many as possible.

With that, I'd like to hand it over to Kyle.

Kyle Guse
Atossa Therapeutics, Inc. - CFO, General Counsel, and Secretary

Well, thank you. Thank you very much for having us here today. Again, I'm Kyle Guse. I'm the CFO and General Counsel of Atossa Therapeutics. I've been with the company for about 10 years now. I went to Atossa just after its IPO. Prior to that, I was practicing law at big law firms in Silicon Valley, doing M&A and capital markets work for biotech companies. And when I came across Atossa and saw what they were doing, I left my law job and moved to Seattle and joined

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot